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Vitamin E is the generic term for a group of lipid-soluble tocol and tocotrienol 
derivatives possessing varying degrees of vitamin activity. The most active of these 
compounds is a-tocopherol, which accounts for approximately 90% of the vitamin E 
found in tissues. The present paper will, therefore, principally consider the absorption 
and transport of a-tocopherol from ingestion to uptake by tissues, including a-tocopheryl 
acetate, which is the most widely used form for vitamin E supplementation. Tocopherols 
are water insoluble, non-swelling amphiphiles. Thus, movement through the aqueous 
phase at appropriate concentrations depends on the abundancy of suitable vehicles 
enabling efficient vitamin E absorption and transport. 
ABSORPTION 
Vitamin E absorption from the intestinal tract is governed by the same intraluminal 
membrane and intracellular events as have been described for other dietary fats such as 
cholesterol or triacylglycerols (Thomson & Dietschy, 1981). The steps include efficient 
emulsification, solubilization within mixed micelles, diffusion across the unstirred water 
layer, permeation through the membrane of the absorptive cells (enterocytes), incorpor- 
ation into lipoprotein particles (chylomicrons), and transport out of the mucosal cell into 
the circulation via lymphatic pathways. 
Intruluminul events. Efficient absorption of a-tocopherol requires the rapid flux of the 
highly hydrophobic molecule through the thick unstirred water layer coating the 
absorptive mucosa of the small intestine. This is achieved by the incorporation of 
a-tocopherol into mixed bile salt micelles which are formed by the combination of 
hydrolysed fat (e.g. monoacylglycerols and free fatty acids) and bile salts in the lumen of 
the small intestine. The aqueous a-tocopherol concentration can be greatly increased by 
micellar solubilization and the resulting very small particles can diffuse in substantial 
amounts across the unstirred water layer to reach the enterocytes. As illustrated in Fig. 
1, mixed micelles possess a much greater capacity to solubilize a-tocopherol and other 
lipids than do pure bile salt micelles. The mixed micelles have a radius of 1.5-5.0 nm 
available at https:/www.cambridge.org/core/terms. https://doi.org/10.1079/PNS19920028
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 11 Jul 2017 at 09:38:52, subject to the Cambridge Core terms of use,
180 W .  COHN A N D  OTHERS 
" 0  1 2 3 4 5 6 7 8 9 10 
a-Tocopherol (mM) 
Fig. 1. Mean hydrodynamic radius of a-tocopherol-containing lipid particles at 37", measured by quasielastic 
light scattering. A hydrodynamic radius of <5 nm indicated complete a-tocopherol solubilization in micelles. 
(A), Taurocholate (25 mM) solubilized a-tocopherol in small micelles of about 1.5 nm radius up to a 
concentration of 2.5 mM, at higher a-tocopherol concentrations both a micellar and an oil phase was obtained. 
Mixed micelles (0) of soya-bean lecithin (12.5 mM), taurocholate (25 mM) and cholesterol (0.3 mM) dissolved 
up to about 7.5 mM-a-tocopherol, which resulted in mixed micelles of a radius between 2.8 and 5.0 nm. Again, 
higher a-tocopherol concentrations resulted in the formation of an oil phase. Micelles were prepared in 30 
mM-potassium phosphate buffer (pH 6.7) containing 150 mM-sodium chloride, using the dissolution method of 
Carey & Small (1978). 
(Fig. 1) compared with emulsion particles with a radius of 100-2500 nm (Carey & Small, 
1970). Thus, fat digestion involves enzymic processing of the ingested lipids, whereby 
complex lipids are degraded into components such as monoacylglycerols, as well as 
physico-chemical events resulting in micellar dispersion of the lipolytic products and 
a-tocopherol. 
Emulsification begins in the stomach by predominantly mechanical forces which break 
up large oil droplets into smaller particles. In the intestine chyme mixes with pancreatic 
and biliary secretions, providing the ingredients necessary for lipid digestion and the 
formation of mixed bile salt micelles. Triacylglycerols are hydrolysed by pancreatic lipase 
to monoacylglycerols and fatty acids which are most efficiently dispersed by bile salts. 
The bile salts are synthesized by the liver and secreted into the small intestine from the 
gall bladder. The obligatory requirement of bile for the intestinal absorption of vitamin E 
has been demonstrated in patients with liver diseases and biliary obstruction (Harries & 
Muller, 1971a; Sokol et al. 1987) and in experimental animals (Gallo-Torres, 1970; 
MacMahon & Thompson, 1970). Additional evidence for the importance of bile salts 
comes from in vitro studies using rat small intestinal slices (Pearson & Legge, 1972) or 
intestinal cells (Traber et al. 19906). Patients with pancreatic insufficiency, as in cystic 
fibrosis, secrete greatly decreased amounts of pancreatic enzymes into the intestinal 
lumen. Such patients also show impaired absorption of a-tocopherol, presumably caused 
by a failure to hydrolyse triacylglycerols, thereby resulting in a decreased capacity for 
a-tocopherol solubilization in mixed micelles (Bennett & Medwadowksi, 1967; Harries 
& Muller, 1971b; Stead et al. 1986). It follows, therefore, that a-tocopherol absorption is 
also dependent on the amount and composition of other fats eaten concurrently. 
Supplements of vitamin E are generally given in the form of a-tocopheryl acetate in 
which the reactive hydroxyl group of a-tocopherol is esterified, thereby increasing the 
stability of the molecule. Because essentially all vitamin E is absorbed by the intestinal 
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Fig. 2. Cumulative recovery of a-tocopherol (0) and other lipids in intestinal lymph. a-Tocopherol (770 nmol) 
was dispersed in cream (triacylglycerol content 458 pnol) and was administered by stomach tube. Rats were 
prepared as described by Gallo-Torres & Miller (1969). (B), Cholesterol; (a), phospholipids; (d), triacyl- 
glycerols. 
mucosa as free a-tocopherol, a-tocopheryl acetate has to be hydrolysed before absorp- 
tion. The principal enzyme responsible for this hydrolysis is pancreatic esterase (Muller 
et al. 1976), which depends on the presence of bile salts both as an essential cofactor as 
well as for solubilizing its substrates. 
Uptake by the enterocyte and intracellular events. Once tocopherol has been solubilized 
in mixed micelles, transport across the unstirred water layer is facilitated and the vitamin 
is ready for mucosal uptake by the brush-border membrane. The results of both in vitro 
and in vivo studies suggest that the rate of vitamin E uptake is controlled by passive 
diffusion (Hollander et al. 1975; Muralidhara & Hollander, 1977). In the rat, maximal 
absorption takes place at the junction between the upper and middle thirds of the 
small intestine (Hollander et al. 1975; Gallo-Torres, 1980). Within the mucosal cell, 
a-tocopherol combines with other lipids and with apoproteins, forming lipoproteins such 
as the chylomicrons, in which form it is transported out of the cells (Bjorneboe et al. 
1986; Traber et al. 1988). Intracellular a-tocopherol transport does not appear to rely on 
a transfer protein (Catignani & Bieri, 1977). Chylomicrons and other lipoproteins con- 
taining a-tocopherol exit the mucosal cells by passing through the basolateral 
membranes, across the lamina propria, and into the lymphatic stream. After ingestion of 
a-tocopherol in cream, about 98% of the vitamin is transported together with the chylo- 
microns and intestinal very-low-density lipoprotein (VLDL; as defined by its flotation 
properties), that is with the triacylglycerol-rich lipoproteins. Thus, as illustrated in Fig. 2, 
the appearance of a-tocopherol in mesenteric lymph parallels triacylglycerol accumula- 
tion. In this experiment the cumulative a-tocopherol recovery 6.5 h after dosage 
amounted to about 70% of the dose administered. A similar extent of absorption was 
found by Traber et al. (1986). However, variable recoveries of a-tocopherol in lymph 
have been reported following cannulation of the thoracic duct in rats (Gallo-Torres, 
1980). Depending on the form and formulation tested, the extent of absorption varied 
between 10 and 65%, probably reflecting differences during the intraluminal phase of 
absorption. Although there is evidence that some of the a-tocopherol may be taken up 
by the portal system (MacMahon et al. 1971; Hollander & Dadufalza, 1989), at least the 
majority of the absorbed tocopherol is carried via the lymphatics to the bloodstream. 
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Fig. 3. Distribution of a-tocopherol (0) among human plasma lipoproteins. Lipoproteins were separated by 
gradient ultracentrifugation (Cohn & Kuhn, 1989). The plasma concentrations of the major lipid components 
in the lipoprotein fractions are shown. (B), Triacylglycerols: (B), cholesterol; (W), phospholipids. 
PLASMA T R A N S P O R T  A N D  T I S S U E  D E L I V E R Y  
Vitamin E is transported in the plasma by the plasma lipoproteins and there is no 
evidence of a specific plasma carrier protein as has been found for vitamins A and D 
(Bjornson et al. 1976; Behrens et al. 1982). In consequence, co-transport of a-tocopherol 
with other circulating lipids ensures protection of polyunsaturated fatty acids from free 
radical attack (Esterbauer et al. 1987). Moreover, plasma vitamin E concentrations do 
not entirely depend on dietary intake, but vary with the lipoprotein concentrations 
(Davies et al. 1969; Honvitt et al. 1972). Normal plasma a-tocopherol concentrations 
range from 11-37 pmolll (Farrell, 1980). 
Lipoprotein distribution. All the lipoprotein fractions contain a-tocopherol, and its 
distribution parallels the distribution of lipids in lipoproteins, as shown in Fig. 3. In the 
human, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) represent 
the most abundant lipoprotein classes and are the major carriers of a-tocopherol. As 
pointed out by Behrens et aE. (1982), more a-tocopherol is found in HDL than in LDL in 
females, whereas in males the opposite is true. The distribution of a-tocopherol in 
lipoproteins does not parallel individual lipid classes such as triacylglycerols, cholesterol 
or phospholipids (Fig. 3), indicating that the vitamin does not share the same metabolic 
fate as any one of these lipids. Furthermore, the lipoprotein distribution of a-tocopherol 
does not reflect the relative importance of individual lipoprotein classes for the transport 
of vitamin E. For example, as discussed earlier, tocopherol enters the systemic 
circulation within chylomicrons, which in terms of turnover are the major camers of 
vitamin E. However, as the secretion of newly synthesized chylomicrons fluctuates with 
the intake of dietary lipids, and clearance of this lipoprotein is fast, plasma concen- 
trations of vitamin E associated with the chylomicron fraction are usually low. Thus, the 
distribution of vitamin E in the plasma lipoproteins represents a steady-state which is 
adjusted by various metabolic processes, as discussed later (p. 185). 
Redistribution during lipoprotein metabolism. The fat transport system can be divided 
into two pathways: an exogenous pathway for dietary lipids absorbed from the intestine 
and an endogenous pathway for lipids entering the bloodstream from the liver and other 
non-intestinal tissues. 
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Fig. 4. Effect of Triton WR 1339 on the appearance of absorbed a-[14C]tocopherol in rat plasma. Labelled 
a-tocopherol (0.93 Fmol) was dispersed in cream (2 ml) at a specific activity of 22.63 pCi/rnmol and 
administered by stomach tube to Triton-treated (0) and control (0) rats (n 3). For Triton treatment, rats were 
injected with the detergent 30 rnin before the ingestion of the labelled tocopherol (Cohn et al. 1988). Values are 
means and one standard deviation expressed as c~-['~C]tocopherol concentrations, since plasma radioactivity 
was shown to represent a-tocopherol exclusively. 
The exogenous pathway. Following its absorption, vitamin E enters the circulation by 
means of chylomicrons and intestinal VLDL. In order to monitor the appearance of 
these intestinal lipoproteins, the intravascular metabolism of chylomicrons and VLDL 
has been blocked by injection of Triton WR 1339 (Otway & Robinson, 1967a,b). Triton 
inhibits the clearance of chylomicrons and VLDL (Risser et al. 1978; Holt & Dominguez, 
1980), rendering these lipoproteins inaccessible for hydrolysis by lipoprotein lipase (EC 
3.1.1.34), an enzyme situated on the capillary endothelial surface of adipose tissue and 
muscle (Nelsson-Ehle et al. 1980). 
The effect of Triton on the appearance of ingested a-[14C]tocopherol in rat plasma is 
shown in Fig. 4. Approximately 30 min after its administration, a-[14C]tocopherol could 
be detected in plasma and, thereafter, the label accumulated linearly with time. Without 
Triton injection, plasma concentrations of absorbed a-[14C]tocopherol in the control rats 
were much lower and mainly increased between 30 and 60 min after dosage. This result 
indicated that the lower vitamin E concentrations found in the control rats were due to 
efficient removal of the vitamin from the plasma and its transfer to tissues. Accordingly, 
150 min after administration of a-[14C]tocopherol recovery from the liver was 4% of the 
dose in the controls, but only 0.3% in Triton-treated rats. Following Triton injection, 
ingested a-[14C]tocopherol accumulated mainly within chylomicrons (Fig. 5(a)), the 
remaining plasma a-tocopherol being confined to the VLDL fraction. These findings 
were in contrast to the post-prandial alterations in lipoprotein a-tocopherol content of 
non-Triton control rats (Fig. 5(b)), where only small amounts of a-[14C]tocopherol were 
associated with VLDL and chylomicrons. The major portion of the a-tocopherol 
accumulated within the density 1.006 infranate, comprising chylomicron remnants, 
intermediate-density lipoprotein (IDL), LDL and HDL. Thus, dietary a-tocopherol 
enters plasma on chylomicrons and VLDL and during their catabolism by lipoprotein 
lipase, a-tocopherol is subsequently transferred to remnants, LDL and HDL. 
These results supplement the findings of Bjorneboe et af. (1986) who injected 
a-[3H]tocopherol-labelled lymph into rats. The a-[3H]tocopherol was cleared from the 
circulation with a half-life of about 12 min, which is in agreement with the half-lives 
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Fig. 5. Effect of Triton WR 1339 on the appearance of absorbed a-[14C]tocopherol in plasma lipoprotein 
fractions. (A). Triton-treated rats; (B), control rats. Lipoproteins were separated as described (Cohn et al. 
1988). Labelled a-tocopherol (0.93 pmol) was dispersed in cream (2 ml) at a specific density of 22.63 pCilmmo1 
and administered by stomach tube to the rats. For Triton treatment, rats were injected with the detergent 30 
min before the ingestion of the labelled tocopherol (Cohn et al. 1988). (0, O), Chylomicrons; ( A ,  A), 
very-low-density lipoprotein; (m), density >1.006 infranate. Values are means and one standard deviation, 
expressed as a-['4C]tocopherol concentrations, since plasma radioactivity was shown to represent a-tocopherol 
exclusively. 
reported for other chylomicron constituents such as retinyl palmitate. At 10 min after 
intravenous injection of chylomicrons, about 8% of the a-[3H]tocopherol was recovered 
in the HDL fraction. The labelled a-tocopherol was preferentially taken up by the liver, 
which after 1 h contained more than 50% of the dose, most of the tracer being recovered 
in parenchymal cells. As discussed later (p. 184), these findings are consistent with a 
preferential a-tocopherol plasma clearance in chylomicron remnants via the apo E 
receptor pathway. 
Efficient removal of newly absorbed a-tocopherol from the circulation depends, 
therefore, on the action of lipoprotein lipase. Under the influence of this enzyme much 
of the a-tocopherol is taken up by the liver or transferred to other lipoproteins. In 
addition, Traber et al. (1985) demonstrated that lipoprotein lipase transfers a-tocopherol 
from chylomicrons to fibroblasts in cell culture during triacylglycerol hydrolysis. Tissues 
capable of synthesizing and secreting lipoprotein lipase, such as adipose tissue and 
muscle, may, therefore, obtain tocopherol by the lipoprotein lipase mechanism. During 
intravascular hydrolysis of triacylglycerols by lipoprotein lipase, some of the core 
material from the chylomicrons or VLDL is removed; consequently, less surface material 
consisting of unesterified cholesterol, phospholipids and apolipoproteins is required 
(Havel, 1987). This redundant material moves along a surface pathway to HDL, and 
apolipoprotein E moves from HDL to chylomicrons or VLDL. Some tocopherol is 
probably transferred with the excess surface material from chylomicrons and VLDL to 
HDL during the hydrolysis of triacylglycerols. Lipoprotein lipase releases remnant 
particles containing the remaining core lipids (cholesteryl esters, triacylglycerols, vitamin 
E, etc.) which are cleared from the circulation by the liver via the apo E receptor 
pathway (Mahley, 1988). 
The endogenous pathway. The endogenous pathway begins with the hepatic secretion 
of VLDL. A number of different in vitro and in vivo studies have shown that 
a-tocopherol is secreted into the bloodstream within nascent VLDL (Bjorneboe et al. 
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1987; Cohn et al. 1988). Since the delivery of dietary a-tocopherol by chylomicrons 
fluctuates with the load of absorbed vitamin E, hepatic VLDL and the endogenous 
pathway are important for maintaining plasma concentrations of a-tocopherol. Using 
deuterated tocopherols, the liver was found to secrete nascent VLDL which were 
enriched in natural a-tocopherol preferentially to y-tocopherol and the other 
stereoisomers of a-tocopherol (Traber et al. 1990a,c,d). This biodiscrimination appears 
to be related to an intracellular tocopherol-binding protein (31 kD), which exhibits 
different binding affinities for the various vitamin E homologues and stereoisomers 
(Catignani & Bieri, 1977; Behrens & Madere, 1982). 
Similarly as described for chylomicrons and intestinal VLDL, hepatic VLDL are also 
metabolized in peripheral tissues by lipoprotein lipase. This results in the formation of 
IDL and eventually LDL. Again lipoprotein lipase could promote the delivery of 
VLDL-a-tocopherol to adipose tissue and muscle as well as mediate a-tocopherol 
transfer to HDL along with other excess surface material of VLDL. Transfer of 
tocopherol from HDL to other lipoproteins could then occur enriching all the lipoprotein 
fractions with the vitamin. a-Tocopherol has been shown to exchange spontaneously 
between different lipoproteins (Massey, 1984). Transfer is efficient from LDL and HDL 
to other lipoproteins, whereas VLDL and chylomicrons are comparatively poor 
a-tocopherol donors (Granot et al. 1988; W. Cohn, unpublished results). The transfer of 
tocopherol between lipoproteins is not assisted by the neutral-lipid transfer protein, 
which promotes the exchange of cholesteryl ester for triacylglycerol between HDL and 
the triacylglycerol-rich lipoproteins (Granot et al. 1988). 
The IDL and LDL produced by the metabolism of hepatic VLDL can be taken up 
both by the liver and by peripheral tissues via LDL (apolipoprotein B E )  receptors 
(Gotto et al. 1986). The high-affinity receptor pathway for LDL has been shown to 
function as a mechanism for a-tocopherol delivery to fibroblasts in tissue culture (Traber 
& Kayden, 1984; Thellman & Shireman, 1985). Consistent with endocytosis of intact 
LDL, both a-tocopherol and apo B, the apolipoprotein of LDL, were taken up together 
in these studies. When LDL was incubated with receptor-negative fibroblasts from a 
patient with homozygous familial hypercholesterolaemia, delivery of a-tocopherol was 
reduced. Uptake of both a-[3H]tocopherol and 1251-labelled LDL by normal fibroblasts 
was greatly reduced when the lipoprotein was modified by methylation, which prevented 
binding of LDL to its receptor (Weisgraber et al. 1978). The residual uptake of 
a-tocopherol from either methylated LDL by normal cells, or from normal LDL by 
LDL-receptor-deficient cells, suggest that the LDL-receptor mechanism is not the only 
pathway for delivery of tocopherols from LDL to cells. This is consistent with the 
observation that patients with the homozygous form of familial hypercholesterolaemia 
do not manifest any biochemical or clinical evidence of vitamin E deficiency. 
The role of the LDL-receptor pathway in the maintenance of a-tocopherol concen- 
trations in tissues of intact animals has been further investigated in the Watanabe 
heritable hyperlipidaemic (WHHL) rabbit (Cohn & Kuhn, 1989). These animals have a 
defect in the intracellular glycosylation of the immature LDL receptor, which causes 
decreased transport of the receptor to the cell surface and a virtual absence of 
LDL-receptor activity (Yamamoto et al. 1986). Thus, WHHL rabbits provide an 
animal model for homozygous familial hypercholesterolaemia. Plasma concentrations of 
a-tocopherol in WHHL rabbits fed on a control diet for 200 d were increased tenfold 
compared with control rabbits, and this was associated with increased concentrations of 
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VLDL, IDL and LDL. Despite the LDL-receptor deficiency in the WHHL animals, 
tissue concentrations of a-tocopherol, with the exception of the adrenal gland, were not 
reduced. The adrenal gland, thus, appears to rely on the LDL-receptor pathway for 
obtaining a significant proportion of its a-tocopherol. Following the injection of LDL 
labelled with a-[3H]tocopherol into both normal and WHHL rabbits, there was evidence 
for transfer of a-[3H]tocopherol to tissues independent of LDL uptake (Cohn et al. 
1992). In addition, a-[3H]tocopherol was found to move between the various lipoprotein 
fractions. The results also indicated that the high concentrations of VLDL, IDL and 
LDL in WHHL rabbits allow more efficient clearance by receptor-independent 
mechanisms. Taken together, these findings show that LDL-a-tocopherol may be 
delivered to tissues by a number of different mechanisms, including uptake of 
a-tocopherol with LDL by receptor-dependent and -independent pathways, and uptake 
of a-tocopherol without concomitant LDL uptake. Moreover, a-tocopherol can 
exchange from LDL to other lipoproteins, which in turn can mediate transfer of 
a-tocopherol to tissues. 
Little is known about HDL-mediated tissue uptake of vitamin E. HDL-binding sites 
recognizing apolipoproteins A-I and A-I1 have been identified on cell surfaces. These 
binding sites are involved in cholesterol efflux from cells to HDL (Oram et al.  1983; 
Aviram et af. 1989; Tozuka & Fidge, 1989). In current studies (W. Cohn, unpublished 
results) the liver was the predominant site of HDL-a-tocopherol uptake, consistent with 
a role for HDL in reverse a-tocopherol transport from tissues to the liver. The adrenal 
gland was the most active tissue per unit wet weight for tocopherol uptake. At 15 min 
after injection of labelled HDL, more than 40% of the a-tocopherol tracer was recovered 
in the liver. Studies with primary cultures of rat hepatocytes confirmed that the transfer 
from HDL to cells was fast and efficient. 
CONCLUSION 
The concepts presented here reflect mainly the progress made in the understanding of 
vitamin E plasma transport during the last decade. However, many aspects of vitamin E 
absorption, allocation to lipoproteins and tissue delivery remain largely unknown. For 
example, we still ignore how a-tocopherol is transported from the brush-border 
membrane of the enterocyte to the golgi complex for incorporation into chylomicrons. 
The question of whether transfer factors are involved in the distribution of a-tocopherol 
within lipoproteins and its movement to tissues remains to be settled. 
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